Frank Pompilio
Keine laufenden Positionen mehr
Profil
Frank Pompilio worked as a Senior Director-Medical Affairs at Kythera Biopharmaceuticals LLC from 2014 to 2016.
He then served as Vice President-Medical Affairs at MannKind Corp.
from 2016 to 2019.
Prior to his industry roles, he was an Assistant Professor-Pharmacy at the University of Southern California.
Currently, he holds the position of Vice President-Medical Affairs at Arcutis Biotherapeutics, Inc. Dr. Pompilio holds a doctorate degree from the University of Southern California and an undergraduate degree from the University of California, Santa Barbara.
Ehemalige bekannte Positionen von Frank Pompilio
| Unternehmen | Position | Ende |
|---|---|---|
| MANNKIND CORPORATION | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2019 |
| KYTHERA BIOPHARMACEUTICALS INC | Technik-/Wissenschafts-/F&E-Leiter | 01.06.2016 |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | Corporate Officer/Principal | - |
| ARCUTIS BIOTHERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Frank Pompilio
| University of Southern California | Doctorate Degree |
| University of California, Santa Barbara | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ARCUTIS BIOTHERAPEUTICS, INC. | Health Technology |
| MANNKIND CORPORATION | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Kythera Biopharmaceuticals LLC
 Kythera Biopharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Kythera Biopharmaceuticals LLC operates as a clinical-stage biopharmaceutical company. It focuses on the discovery, development, and commercialization of novel prescription products for the aesthetic medicine market. The company was founded by Jay Edward Birnbaum, Amit D. Munshi, Nathaniel Eames David, and Keith R. Leonard, Jr. on June 3, 2004 and is headquartered in Westlake, CA. | Health Technology |
